NCT03217097 2025-11-21
MGMT-NET
Hospices Civils de Lyon
Phase NA Completed
Clinical Trials
19 trialsNCT05017662 2025-09-04
A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
Ariceum Therapeutics GmbH
Phase NA Completed
NCT05680675 2025-02-06
Dual-Tracer Theranostic PET
University of Utah
Phase NA Completed
NCT05255133 2025-01-06
Liquid-NET
Universiteit Antwerpen
Phase NA Completed
NCT03288402 2024-06-20
DIB-NET
University Hospitals Coventry and Warwickshire NHS Trust
Phase NA Completed
NCT02472678 2024-05-06
WIN
University Medical Center Groningen
Phase NA Completed
NCT02481804 2024-05-06
DIVIT-pilot
University Medical Center Groningen
Phase NA Completed
NCT03143946 2024-05-06
DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor
University Medical Center Groningen
Phase NA Completed
NCT03834701 2024-02-13
RAPNEN
Catholic University of the Sacred Heart
Phase NA Completed
NCT03873870 2024-01-17
68Ga-DOTATATE PET for Management of Neuroendocrine Tumors
University Health Network, Toronto
Phase NA Completed
NCT06080204 2023-10-18
Real-world Study on Adjuvant Octreotide Therapy in pNETs
Changhai Hospital
Phase NA Completed
NCT02609737 2022-02-01
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01747096 2022-01-21
68-DOTANOC-GEP
Nantes University Hospital
Phase NA Completed
NCT01476592 2019-11-18
A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors
University of Wisconsin, Madison
Phase NA Completed
NCT02125474 2019-11-14
Efficacy of 177-Lu-DOTA 0, Tyr 3 Octreotate
Instituto Nacional de Cancerologia, Columbia
Phase NA Completed
NCT03183271 2017-06-14
Proton Boost for Locally Advanced HEAD AND NECK TUMORS
CNAO National Center of Oncological Hadrontherapy
Phase NA Completed
NCT01099228 2016-07-21
Combination Targeted Radiotherapy in Neuroendocrine Tumors
University of Iowa
Phase NA Completed
NCT02539433 2015-09-03
Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
Northwell Health
Phase NA Completed
NCT00230139 2008-10-15
SPECT/CT in Endocrine and Neuroendocrine Tumors
Rambam Health Care Campus
Phase NA Completed